Point72 Asset Management Reports 1.2% Stake in Dianthus Therapeutics, Inc. (DNTH)

On May 15, 2026, Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen filed a Schedule 13G/A reporting a 1.2% ownership stake in Dianthus Therapeutics, Inc. (DNTH). The reporting persons collectively hold 643,599 shares of common stock as of the event date of March 31, 2026. This position represents an increase from a previous 0.0% ownership level reported in prior filings. Point72 Asset Management serves as the investment manager for the fund holding the shares, while Point72 Capital Advisors, Inc. acts as the general partner and Steven A. Cohen maintains control over both entities. Additionally, Cubist Systematic Strategies, LLC acts as a sub-advisor for a portion of the reported shares. The filing indicates that the shares were acquired for investment purposes and not with the intent of changing or influencing the control of the issuer. The calculation of the ownership percentage is based on an aggregate of 52,942,083 shares outstanding.